You have 9 free searches left this month | for more free features.

Autologous Bone Marrow Mononuclear cell therapy

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Lymphoblastic Leukemia Ph Positive Trial in Spain (Imatinib)

Recruiting
  • Acute Lymphoblastic Leukemia Ph Positive
  • Oviedo, Asturias, Spain
  • +80 more
Jan 17, 2022

Recurrent Leukemia, Refractory Leukemia Trial in Houston (Decitabine, Tegavivint)

Recruiting
  • Recurrent Leukemia
  • Refractory Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Dec 31, 2022

Resectable Soft Tissue Sarcoma, Stage I Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8, Stage IA Soft Tissue Sarcoma

Recruiting
  • Resectable Soft Tissue Sarcoma
  • +4 more
  • Hypofractionated Radiation Therapy
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 5, 2023

Osteoarthritis Trial in Greenslopes (G7 HA Acetabular Component, G7 PPS Acetabular Component)

Completed
  • Osteoarthritis
  • G7 HA Acetabular Component
  • G7 PPS Acetabular Component
  • Greenslopes, Queensland, Australia
    Greenslopes Private Hospital
Jan 12, 2022

Sarcoma, Bone Tumor Trial in France (Patient specific instrument, Conventional surgical treatment)

Completed
  • Sarcoma, Bone Tumor
  • Patient specific instrument
  • Conventional surgical treatment
  • Lille, France
  • +7 more
Jul 27, 2021

Vascular Dementia Trial in Russian Federation (Prospecta, Placebo)

Completed
  • Vascular Dementia
  • Arkhangelsk, Russian Federation
  • +32 more
Jan 20, 2023

Dry Age Related Macular Degeneration Trial in United States (MA09-hRPE)

Completed
  • Dry Age Related Macular Degeneration
  • MA09-hRPE
  • Los Angeles, California
  • +3 more
Jul 4, 2021

Cultural Tailoring and Pilot Testing ofInpatient Yoga Therapy

Not yet recruiting
  • Hematopoietic Stem Cell Transplantation
  • Cancer
  • Yoga Sessions
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 27, 2022

Identify Biomarkers of Pulmonary Toxicity for Immune Checkpoint

Recruiting
  • Pneumonitis, Interstitial
  • +2 more
  • Immune checkpoint blockade
  • +2 more
  • Leuven, Flemish Brabant, Belgium
    Universitaire Ziekenhuizen Leuven
Mar 18, 2021

Lung Cancer, Organoid, NSCLC Trial in Wuxi (Antitumor therapy guided by organoid drug sensitivity test)

Recruiting
  • Lung Cancer
  • +2 more
  • Antitumor therapy guided by organoid drug sensitivity test
  • Wuxi, Jiangsu, China
    Affiliated Hospital of Jiangnan University
Feb 2, 2023

Efficacy, and Optimal Dose Finding Study for Multiple Myeloma

Recruiting
  • Multiple Myeloma
    • Bucheon, Korea, Republic of
    • +23 more
    Dec 8, 2020

    NSCLC Trial in Porto (Durvalumab, standard of care RT/RCT)

    Recruiting
    • Non-small Cell Lung Cancer
    • Porto, Portugal
      Instituto Português de Oncologia do Porto FG, EPE (IPO-Porto)
    Feb 23, 2022

    Sickle Cell Disease, Cognitive Impairment, Adolescent Behavior Trial in Birmingham (CREADY (Cognitive-Remediation of Executive

    Recruiting
    • Sickle Cell Disease
    • +5 more
    • CREADY (Cognitive-Remediation of Executive and Adaptive Deficits in Youth)
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Jul 20, 2022

    Sickle Cell Disease, Vaso-occlusive Crisis Trial in Rouen (Erythrocytic parameters and thrombin generation assay measurement)

    Recruiting
    • Sickle Cell Disease
    • Vaso-occlusive Crisis
    • Erythrocytic parameters and thrombin generation assay measurement
    • Rouen, France
      Rouen university Hospital
    May 17, 2022

    Esophageal Carcinoma, Esophagogastric Junction Carcinoma Trial (pembrolizumab)

    Completed
    • Esophageal Carcinoma
    • Esophagogastric Junction Carcinoma
    • pembrolizumab
    • (no location specified)
    Aug 18, 2022

    Fistula Vagina, Crohn Disease Trial in Rochester (MSC-AFP)

    Completed
    • Fistula Vagina
    • Crohn Disease
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Oct 28, 2020

    Stage IIIA NSCLC, Stage IIIB NSCLC, Stage IV NSCLC Trial in Los Angeles (Laboratory Biomarker Analysis, Pembrolizumab)

    Completed
    • Stage IIIA Non-Small Cell Lung Cancer
    • +2 more
    • Laboratory Biomarker Analysis
    • Pembrolizumab
    • Los Angeles, California
      UCLA / Jonsson Comprehensive Cancer Center
    Jun 24, 2021

    Survival of Adult T-cell Leukemia / Lymphoma and Patients

    Recruiting
    • Lymphoproliferation Induced by HTLV-1
    • +2 more
      • Paris, France
        Hôpital Necker Enfants Malades
      Sep 26, 2022

      LIFE - Lung Cancer, Immunotherapy, Frailty, Effect

      Active, not recruiting
      • Non-small Cell Lung Cancer
      • +3 more
      • CT-scans extended
      • +3 more
      • Odense, Denmark
        Department of Oncology, Odense University Hospital
      May 17, 2022

      Mucositis Oral Trial in France (LLLT applied every other day, LLLT applied daily)

      Unknown status
      • Mucositis Oral
      • LLLT applied every other day
      • LLLT applied daily
      • Toulouse, Occitanie, France
      • +15 more
      Oct 15, 2020

      Non Small Cell Lung Cancer Trial in Tianjin (Osimertinib, Bevacizumab Biosimilar IBI305, Carboplatin)

      Recruiting
      • Non Small Cell Lung Cancer
      • Tianjin, Tianjin, China
        Tianjin Medical University Cancer Institute and Hospital
      Aug 18, 2022

      Locally Advanced Rectal Cancer, Total Neoadjuvant Treatment, Anti-PD-1 Trial in Changchun (nCRT ? (CapeOX+Sintilimab)×6 ?

      Not yet recruiting
      • Locally Advanced Rectal Cancer
      • +2 more
      • nCRT → (CapeOX+Sintilimab)×6 → Surgery/W&W
      • Changchun, Ji Lin, China
        First Hospital of Jilin University
      Aug 11, 2023

      Helicobacter Pylori Infection Trial (7days bismuth quadruple, 14 days bismuth quadruple)

      Not yet recruiting
      • Helicobacter Pylori Infection
      • 7days bismuth quadruple
      • 14 days bismuth quadruple
      • (no location specified)
      Aug 11, 2023

      Metastatic Breast Cancer, Tumor, Muscle Tumors Trial in Colorado Springs (Method(s)1 Attribution, Method(s)2 Attribution,)

      Not yet recruiting
      • Metastatic Breast Cancer
      • +3 more
      • Method(s)1 Attribution
      • Method(s)2 Attribution,
      • Colorado Springs, Colorado
        PNAF Medical
      Nov 23, 2023

      Schizophrenia, Psychosis, Psychotic Disorders Trial (Cognitive Behavioural Therapy for Psychosis (CBTp), Cognitive Remediation

      Not yet recruiting
      • Schizophrenia
      • +3 more
      • Cognitive Behavioural Therapy for Psychosis (CBTp)
      • +3 more
      • (no location specified)
      Feb 7, 2023